153 related articles for article (PubMed ID: 19646479)
1. A three-plasmid system for construction of armed oncolytic adenovirus.
Liu HY; Han BJ; Zhong YX; Lu ZZ
J Virol Methods; 2009 Dec; 162(1-2):8-13. PubMed ID: 19646479
[TBL] [Abstract][Full Text] [Related]
2. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
3. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
4. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
5. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant adenovirus type 41 vector and its biological properties.
Lu ZZ; Zou XH; Dong LX; Qu JG; Song JD; Wang M; Guo L; Hung T
J Gene Med; 2009 Feb; 11(2):128-38. PubMed ID: 19097028
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
8. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY
Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
[TBL] [Abstract][Full Text] [Related]
9. CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells.
Li Y; Li YF; Si CZ; Zhu YH; Jin Y; Zhu TT; Liu MY; Liu GY
Virus Res; 2016 Jul; 220():172-8. PubMed ID: 27157859
[TBL] [Abstract][Full Text] [Related]
10. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
11. [Construction of recombinant adenovirus containing mIkappaBalpha gene by homogenous recombination in E.coli. and its expression in Hep G2 cells].
Jin WD; Chen LH; Mu F
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):308-12. PubMed ID: 15772000
[TBL] [Abstract][Full Text] [Related]
12. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
13. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
14. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
15. [Construction and expression of replication-deficient recombinant adenovirus vector with hNET gene by adeasy-1 system].
Jia ZY; Ou XH; Wei HY; Deng HF; Huang R; Wang JR; Zhang SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):523-6. PubMed ID: 18798484
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
17. [The effect of oncolytic adenovirus on human umbilical vein endothelial cell].
Ye ZM; Wang XH; Zhong J; Miao JC; Sheng WH; Xie YF; Wang JZ; Yang JC
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):397-402. PubMed ID: 16755917
[TBL] [Abstract][Full Text] [Related]
18. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
19. Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L.
Liu GY; Li ZJ; Li QL; Jin Y; Zhu YH; Wang YH; Liu MY; Li YG; Li Y
Int Immunopharmacol; 2015 Sep; 28(1):487-93. PubMed ID: 26208317
[TBL] [Abstract][Full Text] [Related]
20. [Construction of recombinant adenovirus vector of mouse keratinocyte growth factor].
Chen L; Zhang XL; Li YP; Wang JL; Li TS
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Oct; 19(10):610-3. PubMed ID: 17945084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
